Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.58 |
| ▸ | DAO | P14920 | 2/20 | 0.46 |
| ▸ | PDE2A | O00408 | 3/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 3/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | MPL | P40238 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | PKLR | P30613 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3632101 | 0.84 | IDO1 (0.54) | IDO1DAOPDE2ASLC6A4SLC6A2 | |
| SCHEMBL16758990 | 0.83 | IDO1 (0.58) | IDO1DAOPDE2ASLC6A4HTR2A | |
| SCHEMBL10970057 | 0.83 | IDO1 (0.41) | IDO1DAO | |
| SCHEMBL11537101 | 0.83 | IDO1 (0.43) | IDO1DAOPDE2ASLC6A4HTR2A | |
| SCHEMBL6644304 | 0.82 | PON1 (0.45) | IDO1KDM4EPKM | |
| SCHEMBL1873922 | 0.79 | DAO (0.46) | IDO1DAOSLC6A4HTR2AKCNH2 | |
| SCHEMBL5111503 | 0.79 | DAO (0.46) | IDO1DAOPDE2ASLC6A4HTR2A | |
| SCHEMBL17864260 | 0.79 | IDO1 (0.58) | IDO1DAOPDE2ASLC6A4SLC6A2 | |
| SCHEMBL7977134 | 0.79 | IDO1 (0.62) | IDO1DAOPDE2ASLC6A4SLC6A2 | |
| SCHEMBL30617195 | 0.79 | DAO (0.46) | IDO1DAOPDE2ASLC6A4HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250099448-A1 | HETEROCYCLIC COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 2025-03-27 | — | — | US | disclosed |
| US-20070287699-A1 | ANTIVIRAL AGENTS | VIROBAY, INC. (US) | 2007-12-13 | — | — | US | disclosed |
| WO-2007130499-A2 | ANTIVIRAL AGENTS | VIROBAY, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
| CN-1058963-C | Triazole derivative, insecticidal/acaricidal agent, and process for producing the same | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2000-11-29 | — | — | CN | disclosed |
| EP-0648752-B1 | TRIAZOLE DERIVATIVE, INSECTICIDAL/ACARICIDAL AGENT, AND PROCESS FOR PRODUCING THE SAME | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1999-10-06 | — | — | EP | disclosed |
| US-5700824-A | Triazole derivatives, insecticide, acaricide and methods thereof | KUMIAI CHEMICAL INDUSTRIAL CO. LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| US-5616594-A | Triazole derivatives, insecticide, acaricide and methods thereof | IHARA CHEMICAL INDUSTRY CO. LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| CN-1105179-A | Triazole derivative, insecticidal/acaricidal agent, and process for producing the same | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1995-07-12 | — | — | CN | disclosed |
| EP-0648752-A1 | TRIAZOLE DERIVATIVE, INSECTICIDAL/ACARICIDAL AGENT, AND PROCESS FOR PRODUCING THE SAME | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099448-A1 | HETEROCYCLIC COMPOUNDS | OPRM1, CYP1A1, CYP3A4 | IDO1 805/4885DAO 1249/4885PDE2A 1875/4885 |
| US-20070287699-A1 | ANTIVIRAL AGENTS | EIF2AK2, MAVS, ZC3HAV1 | IDO1 1751/4885DAO 962/4885PDE2A 2052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.